Contact: Vicki Cohn, (914) 740-2156, email@example.com
New Clinical Guidelines for Managing Hypothyroid Disease Presented in Thyroid Journal
New Rochelle, NY, September 12, 2012—New evidence-based guidelines have been released for the diagnosis and treatment of hypothyroidism, a complex disease caused by an underactive thyroid gland that cannot produce enough thyroid hormone. These updated clinical recommendations are published in Thyroid, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The new guidelines, developed jointly by the American Thyroid Association (ATA) and American Association of Clinical Endocrinologists (AACE), are available free online on the Thyroid website.
A task force representing the ATA and AACE reviewed the medical literature and current standards of care and developed updated recommendations that are presented in the article by lead author Jeffrey R. Garber, MD, Harvard Vanguard Medical Associates and Beth Israel Deaconess Medical Center, Boston, MA, and colleagues.
“The members of the guidelines committee should be congratulated for providing a state-of-the-science update on the diagnosis and treatment of hypothyroidism, and for giving practitioners practical recommendations on how to manage this common clinical condition,” says James A. Fagin, MD, president of the American Thyroid Association (ATA).
Charles H. Emerson, MD, Editor-in-Chief of Thyroid and Professor Emeritus of Medicine, University of Massachusetts Medical School, Worcester, MA, says “The guidelines address a wide-ranging number of issues that clinicians encounter in treating a disorder that affects millions of men worldwide and an even far greater number of women. They deal firmly with the problem of inappropriate thyroid hormone administration, both as it concerns individuals who should not be taking thyroid hormone, and patients with hypothyroidism who are given or self-administer suboptimal doses or dangerous formulations for their condition.”
About the Journal
Thyroid, the Official Journal of the American Thyroid Association is an authoritative peer-reviewed journal published monthly in print and online. The Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed online on the Thyroid website.
About the Society
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,400 members from 43 countries around the world. Celebrating its 88th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, Thyroid, Clinical Thyroidology and Clinical Thyroidology for Patients; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease. The ATA has extensive online information at www.thyroid.org on thyroid disease for patients in both English and Spanish and serves as the clinical resource for patients and the public who look for reliable information on the Internet.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Journal of Women’s Health, Diabetes Technology & Therapeutics, and Metabolic Syndrome and Related Disorders. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website.